Business
What Goldman Sachs is saying about the CSL (ASX:CSL) share price after its R&D update
Image source: Getty Images
Last week was a reasonably disappointing one for the CSL Limited (ASX: CSL) share price.
Despite releasing its research and development (R&D) update for 2021, the biotherapeutics company’s shares ended the period with a weekly decline of 0.5%.
What was the reaction…
Continue Reading
-
General20 hours agoOf saints and sinners | The Spectator Australia
-
General20 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News10 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General20 hours agoWhy the nation needs the Nationals to ditch Net Zero